![Laurence Reid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurence Reid
Director/Board Member at
METAGENOMI THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Laurence E.
Reid is currently Chairman at Broken String Biosciences Ltd., Director at The Possible Project, Inc., Director at Metagenomi Therapeutics, Inc. since 2025, and Director at Stratus Therapeutics, Inc. since 2022.
Former roles include President, Chief Executive Officer & Director at Warp Drive Bio, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Decibel Therapeutics, Inc. from 2020 to 2023; Independent Director at KalVista Pharmaceuticals, Inc. from 2024 to 2026; VP-Business Development & Strategic Planning at Millennium Pharmaceuticals, Inc. from 1993 to 2003; Chief Business Officer at Ensemble Therapeutics Corp.; General Manager at Millennium UK Ltd; and Chief Business Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc. from 2010 to 2014.
Education includes undergraduate studies at the University of Cambridge and a doctorate from King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-05-30 |
Laurence Reid active positions
| Companies | Position | Start |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Director/Board Member | 2025-08-10 |
The Possible Project, Inc. | Director/Board Member | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Director/Board Member | 2022-01-04 |
Broken String Biosciences Ltd.
 Broken String Biosciences Ltd. BiotechnologyHealth Technology Develops novel cell and gene therapies | Chairman | - |
Former positions of Laurence Reid
| Companies | Position | End |
|---|---|---|
| KALVISTA PHARMA | Director/Board Member | 2026-06-10 |
| DECIBEL THERAPEUTICS, INC. | Chief Executive Officer | 2023-09-21 |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Chief Executive Officer | 2018-09-30 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-12-30 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Training of Laurence Reid
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Millennium UK Ltd
 Millennium UK Ltd Miscellaneous Commercial ServicesCommercial Services Consulting services | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
The Possible Project, Inc. | |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Broken String Biosciences Ltd.
Broken String Biosciences Ltd. BiotechnologyHealth Technology Develops novel cell and gene therapies | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
- Stock Market
- Insiders
- Laurence Reid
